Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
Academic Radiology
|
March 24, 2000
Improving the quality of care through routine teleradiology consultation
H Kangarloo, J A Valdez, L Yao, et al.
Leukemia
|
December 14, 2012
Cell of origin determines clinically relevant subtypes of MLL-rearranged AML
A V Krivtsov, M E Figueroa, A U Sinha, et al.
Cancer Cell
|
November 4, 2008
H3K79 methylation profiles define murine and human MLL-AF4 leukemias
Andrei V Krivtsov, Zhaohui Feng, Madeleine E Lemieux, et al.
Blood
|
January 31, 2013
Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l
Aniruddha J Deshpande, Liying Chen, Maurizio Fazio, et al.
Nature
|
March 6, 2012
Chromatin-modifying enzymes as modulators of reprogramming
Tamer T Onder, Nergis Kara, Anne Cherry, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 31, 2001
Design and synthesis of glycolic and mandelic acid derivatives as factor Xa inhibitors
T Su, Y Wu, B Doughan, et al.
Cancer Cell
|
July 12, 2011
MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L
Kathrin M Bernt, Nan Zhu, Amit U Sinha, et al.
The Journal of Clinical Investigation
|
March 2, 2016
MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia
Simone S Riedel, Jessica N Haladyna, Matthew Bezzant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2010
MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1
Przemyslaw Juszczynski, Scott J Rodig, Jing Ouyang, et al.
Cell Stem Cell
|
September 11, 2012
mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis
Demetrios Kalaitzidis, Stephen M Sykes, Zhu Wang, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
Academic Radiology
|
March 24, 2000
Improving the quality of care through routine teleradiology consultation
H Kangarloo, J A Valdez, L Yao, et al.
Leukemia
|
December 14, 2012
Cell of origin determines clinically relevant subtypes of MLL-rearranged AML
A V Krivtsov, M E Figueroa, A U Sinha, et al.
Cancer Cell
|
November 4, 2008
H3K79 methylation profiles define murine and human MLL-AF4 leukemias
Andrei V Krivtsov, Zhaohui Feng, Madeleine E Lemieux, et al.
Blood
|
January 31, 2013
Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l
Aniruddha J Deshpande, Liying Chen, Maurizio Fazio, et al.
Nature
|
March 6, 2012
Chromatin-modifying enzymes as modulators of reprogramming
Tamer T Onder, Nergis Kara, Anne Cherry, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 31, 2001
Design and synthesis of glycolic and mandelic acid derivatives as factor Xa inhibitors
T Su, Y Wu, B Doughan, et al.
Cancer Cell
|
July 12, 2011
MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L
Kathrin M Bernt, Nan Zhu, Amit U Sinha, et al.
The Journal of Clinical Investigation
|
March 2, 2016
MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia
Simone S Riedel, Jessica N Haladyna, Matthew Bezzant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2010
MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1
Przemyslaw Juszczynski, Scott J Rodig, Jing Ouyang, et al.
Cell Stem Cell
|
September 11, 2012
mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis
Demetrios Kalaitzidis, Stephen M Sykes, Zhu Wang, et al.
Page
of 10